Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database

ACS Chemical Biology

Volumn 11, Issue 7, 2016, Pages 1773-1783

  Sterner, Eric ^a   Flanagan, Natalie ^a   Gildersleeve, Jeffrey C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BLOOD GROUP ANTIGEN; CARBOHYDRATE; GLYCAN ANTIBODY; GLYCAN DERIVATIVE; GLYCOLIPID; GLYCOSAMINOGLYCAN; GLYCOSPHINGOLIPID; MONOCLONAL ANTIBODY; N GLYCAN; O GLYCAN; UNCLASSIFIED DRUG; POLYSACCHARIDE;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; FACTUAL DATABASE; HUMAN; NONHUMAN; PRIORITY JOURNAL; CHEMISTRY; DATABASE MANAGEMENT SYSTEM; IMMUNOLOGY;

ANTIBODIES; DATABASE MANAGEMENT SYSTEMS; GLYCOLIPIDS; POLYSACCHARIDES;

EID: 84978636422     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.6b00244     Document Type: Article

References (78)

1. (2012) Biologic drugs set to top 2012 sales, Nat. Med. 18, 636. 10.1038/nm0512-636a
2. (2012) In Transforming Glycoscience: A Roadmap for the Future, National Academies Press, Washington, DC.
3. Bertozzi, C. R. and Rabuka, D. (2009) Structural Basis of Glycan Diversity, in Essentials of Glycobiology (Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., and Etzler, M. E., Eds.), 2 nd ed., Cold Spring Harbor, New York.
4. Muthana, S. M., Campbell, C. T., and Gildersleeve, J. C. (2012) Modifications of glycans: biological significance and therapeutic opportunities ACS Chem. Biol. 7, 31-43 10.1021/cb2004466
5. Feizi, T. and Childs, R. A. (1985) Carbohydrate structures of glycoproteins and glycolipids as differentiation antigens, tumor-associated antigens and components of receptor systems Trends Biochem. Sci. 10, 24-29 10.1016/0968-0004(85)90012-X
6. Bush, C. A., Martin-Pastor, M., and Imbery, A. (1999) Structure and conformation of complex carbohydrates of glycoproteins, glycolipids, and bacterial polysaccharides Annu. Rev. Biophys. Biomol. Struct. 28, 269-293 10.1146/annurev.biophys.28.1.269
7. Borgert, A., Heimburg-Molinaro, J., Song, X. Z., Lasanajak, Y., Ju, T. Z., Liu, M., Thompson, P., Ragupathi, G., Barany, G., Smith, D. F., Cummings, R. D., and Live, D. (2012) Deciphering structural elements of mucin glycoprotein recognition ACS Chem. Biol. 7, 1031-1039 10.1021/cb300076s
8. Ohyabu, N., Hinou, H., Matsushita, T., Izumi, R., Shimizu, H., Kawamoto, K., Numata, Y., Togame, H., Takemoto, H., Kondo, H., and Nishimura, S. I. (2009) An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library J. Am. Chem. Soc. 131, 17102-17109 10.1021/ja903361f
9. Wandall, H. H., Blixt, O., Tarp, M. A., Pedersen, J. W., Bennett, E. P., Mandel, U., Ragupathi, G., Livingston, P. O., Hollingsworth, M. A., Taylor-Papadimitriou, J., Burchell, J., and Clausen, H. (2010) Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes Cancer Res. 70, 1306-1313 10.1158/0008-5472.CAN-09-2893
10. Kabat, E. A. and Bezer, A. E. (1958) The effect of variation in molecular weight on the antigenicity of dextran in man Arch. Biochem. Biophys. 78, 306-318 10.1016/0003-9861(58)90354-0
11. Kabat, E. A. (1954) Some configurational requirements and dimensions of the combining site on an antibody to a naturally occurring antigen J. Am. Chem. Soc. 76, 3709-3713 10.1021/ja01643a034
12. Cummings, R. D. (2009) The repertoire of glycan determinants in the human glycome Mol. BioSyst. 5, 1087-1104 10.1039/b907931a
13. Cheung, N. K. V., Cheung, I. Y., Kramer, K., Modak, S., Kuk, D., Pandit-Taskar, N., Chamberlain, E., Ostrovnaya, I., and Kushner, B. H. (2014) Key role for myeloid cells: phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma Int. J. Cancer 135, 2199-2205 10.1002/ijc.28851
14. Cheung, N. K., Kushner, B. H., Yeh, S. D., and Larson, S. M. (1998) 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study Int. J. Oncol. 12, 1299-1306 10.3892/ijo.12.6.1299
15. Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., Shimada, H., Grupp, S. A., Seeger, R., Reynolds, C. P., Buxton, A., Reisfeld, R. A., Gillies, S. D., Cohn, S. L., Maris, J. M., and Sondel, P. M. (2010) Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma N. Engl. J. Med. 363, 1324-1334 10.1056/NEJMoa0911123
16. Houghton, A. N., Mintzer, D., Cordoncardo, C., Welt, S., Fliegel, B., Vadhan, S., Carswell, E., Melamed, M. R., Oettgen, H. F., and Old, L. J. (1985) Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase-I trial in patients with malignant-melanoma Proc. Natl. Acad. Sci. U. S. A. 82, 1242-1246 10.1073/pnas.82.4.1242
17. Scott, A. M., Lee, F. T., Hopkins, W., Cebon, J. S., Wheatley, J. M., Liu, Z. Q., Smyth, F. E., Murone, C., Sturrock, S., MacGregor, D., Hanai, N., Inoue, K., Yamasaki, M., Brechbiel, M. W., Davis, I. D., Murphy, R., Hannah, A., Lim-Joon, M., Chan, T., Chong, G., Ritter, G., Hoffman, E. W., Burgess, A. W., and Old, L. J. (2001) Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial J. Clin. Oncol. 19, 3976-3987
18. Livingston, P. O., Hood, C., Krug, L. M., Warren, N., Kris, M. G., Brezicka, T., and Ragupathi, G. (2005) Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy Cancer Immunol. Immunother. 54, 1018-1025 10.1007/s00262-005-0663-8
19. Brezicka, F. T., Olling, S., Nilsson, O., Bergh, J., Holmgren, J., Sorenson, S., Yngvason, F., and Lindholm, L. (1989) Immunohistological detection of fucosyl-GM1 ganglioside in human-lung cancer and normal-tissues with monoclonal-antibodies Cancer Res. 49, 1300-1305
20. Nilsson, O., Brezicka, F. T., Holmgren, J., Sorenson, S., Svennerholm, L., Yngvason, F., and Lindholm, L. (1986) Detection of a ganglioside antigen associated with small-cell lung carcinomas using monoclonal-antibodies directed against fucosyl-GM1 Cancer Res. 46, 1403-1407
21. Scott, A. M., Tebbutt, N., Lee, F. T., Cavicchiolo, T., Liu, Z. Q., Gill, S., Poon, A. M. T., Hopkins, W., Smyth, F. E., Murone, C., MacGregor, D., Papenfuss, A. T., Chappell, B., Saunder, T. H., Brechbiel, M. W., Davis, I. D., Murphy, R., Chong, G., Hoffman, E. W., and Old, L. J. (2007) A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen Clin. Cancer Res. 13, 3286-3292 10.1158/1078-0432.CCR-07-0284
22. Posey, J. A., Khazaeli, M. B., Bookman, M. A., Nowrouzi, A., Grizzle, W. E., Thornton, J., Carey, D. E., Lorenz, J. M., Sing, A. P., Siegall, C. B., LoBuglio, A. F., and Saleh, M. N. (2002) A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors Clin. Cancer Res. 8, 3092-3099
23. Pai, L. H., Wittes, R., Setser, A., Willingham, M. C., and Pastan, I. (1996) Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin Nat. Med. 2, 350-353 10.1038/nm0396-350
24. Ross, H. J., Hart, L. L., Swanson, P. M., Rarick, M. U., Figlin, R. A., Jacobs, A. D., McCune, D. E., Rosenberg, A. H., Baron, A. D., Grove, L. E., Thorn, M. D., Miller, D. M., Drachman, J. G., and Rudin, C. M. (2006) A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma Lung Cancer 54, 69-77 10.1016/j.lungcan.2006.05.020
25. Boeck, S., Haas, M., Laubender, R. P., Kullmann, F., Klose, C., Bruns, C. J., Wilkowski, R., Stieber, P., Holdenrieder, S., Buchner, H., Mansmann, U., and Heinemann, V. (2010) Application of a time-varying covariate model to the analysis of CA 19-9 as serum biomarker in patients with advanced pancreatic cancer Clin. Cancer Res. 16, 986-994 10.1158/1078-0432.CCR-09-2205
26. Hess, V., Glimelius, B., Grawe, P., Dietrich, D., Bodoky, G., Ruhstaller, T., Bajetta, E., Saletti, P., Figer, A., Scheithauer, W., and Herrmann, R. (2008) CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial Lancet Oncol. 9, 132-138 10.1016/S1470-2045(08)70001-9
27. Sawada, R., Sun, S. M., Wu, X., Hong, F., Ragupathi, G., Livingston, P. O., and Scholz, W. W. (2011) Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity Clin. Cancer Res. 17, 1024-1032 10.1158/1078-0432.CCR-10-2640
28. Martinez-Saez, N., Castro-Lopez, J., Valero-Gonzalez, J., Madariaga, D., Companon, I., Somovilla, V. J., Salvado, M., Asensio, J. L., Jimenez-Barbero, J., Avenoza, A., Busto, J. H., Bernardes, G. J., Peregrina, J. M., Hurtado-Guerrero, R., and Corzana, F. (2015) Deciphering the non-equivalence of serine and threonine O-glycosylation points: Implications for molecular recognition of the Tn antigen by an anti-MUC1 antibody Angew. Chem., Int. Ed. 54, 9830-9834 10.1002/anie.201502813
29. Broecker, F., Anish, C., and Seeberger, P. H. (2015) Generation of Monoclonal Antibodies against Defined Oligosaccharide Antigens Methods Mol. Biol. 1331, 57-80 10.1007/978-1-4939-2874-3-5
30. Zarschler, K., Janesch, B., Pabst, M., Altmann, F., Messner, P., and Schaffer, C. (2010) Protein tyrosine O-glycosylation-a rather unexplored prokaryotic glycosylation system Glycobiology 20, 787-798 10.1093/glycob/cwq035
31. Michaelsson, E., Malmstrom, V., Reis, S., Engstrom, A., Burkhardt, H., and Holmdahl, R. (1994) T cell recognition of carbohydrates on type II collagen J. Exp. Med. 180, 745-749 10.1084/jem.180.2.745
32. Kieliszewski, M. J., O'Neill, M., Leykam, J., and Orlando, R. (1995) Tandem mass spectrometry and structural elucidation of glycopeptides from a hydroxyproline-rich plant cell wall glycoprotein indicate that contiguous hydroxyproline residues are the major sites of hydroxyproline O-arabinosylation J. Biol. Chem. 270, 2541-2549 10.1074/jbc.270.6.2541
33. Marino, K., Bones, J., Kattla, J. J., and Rudd, P. M. (2010) A systematic approach to protein glycosylation analysis: a path through the maze Nat. Chem. Biol. 6, 713-723 10.1038/nchembio.437
34. Radhakrishnan, P., Dabelsteen, S., Madsen, F. B., Francavilla, C., Kopp, K. L., Steentoft, C., Vakhrushev, S. Y., Olsen, J. V., Hansen, L., Bennett, E. P., Woetmann, A., Yin, G., Chen, L., Song, H., Bak, M., Hlady, R. A., Peters, S. L., Opavsky, R., Thode, C., Qvortrup, K., Schjoldager, K. T., Clausen, H., Hollingsworth, M. A., and Wandall, H. H. (2014) Immature truncated O-glycophenotype of cancer directly induces oncogenic features Proc. Natl. Acad. Sci. U. S. A. 111, E4066-4075 10.1073/pnas.1406619111
35. Ly, M., Laremore, T. N., and Linhardt, R. J. (2010) Proteoglycomics: recent progress and future challenges OMICS 14, 389-399 10.1089/omi.2009.0123
36. Moloney, D. J., Lin, A. I., and Haltiwanger, R. S. (1997) The O-linked fucose glycosylation pathway. Evidence for protein-specific elongation of O-linked fucose in Chinese hamster ovary cells J. Biol. Chem. 272, 19046-19050 10.1074/jbc.272.30.19046
37. Shao, L., Luo, Y., Moloney, D. J., and Haltiwanger, R. S. (2002) O-Glycosylation of EGF repeats: identification and initial characterization of a UDP-glucose: protein O-glucosyltransferase Glycobiology 12, 763-770 10.1093/glycob/cwf085
38. De Groot, P. W., Ram, A. F., and Klis, F. M. (2005) Features and functions of covalently linked proteins in fungal cell walls Fungal Genet. Biol. 42, 657-675 10.1016/j.fgb.2005.04.002
39. Strahl-Bolsinger, S., Gentzsch, M., and Tanner, W. (1999) Protein O-mannosylation Biochim. Biophys. Acta, Gen. Subj. 1426, 297-307 10.1016/S0304-4165(98)00131-7
40. Tsuboi, S. and Fukuda, M. (2001) Roles of O-linked oligosaccharides in immune responses BioEssays 23, 46-53 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V
41. Tsuboi, S., Sutoh, M., Hatakeyama, S., Hiraoka, N., Habuchi, T., Horikawa, Y., Hashimoto, Y., Yoneyama, T., Mori, K., Koie, T., Nakamura, T., Saitoh, H., Yamaya, K., Funyu, T., Fukuda, M., and Ohyama, C. (2011) A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans EMBO J. 30, 3173-3185 10.1038/emboj.2011.215
42. Vavasseur, F., Dole, K., Yang, J., Matta, K. L., Myerscough, N., Corfield, A., Paraskeva, C., and Brockhausen, I. (1994) O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer Eur. J. Biochem. 222, 415-424 10.1111/j.1432-1033.1994.tb18880.x
43. Vavasseur, F., Yang, J. M., Dole, K., Paulsen, H., and Brockhausen, I. (1995) Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R β3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines Glycobiology 5, 351-357 10.1093/glycob/5.3.351
44. Tsuboi, S., Hatakeyama, S., Ohyama, C., and Fukuda, M. (2012) Two opposing roles of O-glycans in tumor metastasis Trends Mol. Med. 18, 224-232 10.1016/j.molmed.2012.02.001
45. Singh, D. G., Lomako, J., Lomako, W. M., Whelan, W. J., Meyer, H. E., Serwe, M., and Metzger, J. W. (1995) β-Glucosylarginine: a new glucose-protein bond in a self-glucosylating protein from sweet corn FEBS Lett. 376, 61-64 10.1016/0014-5793(95)01247-6
46. Falkowska, E., Le, K. M., Ramos, A., Doores, K. J., Lee, J. H., Blattner, C., Ramirez, A., Derking, R., van Gils, M. J., Liang, C. H., McBride, R., von Bredow, B., Shivatare, S. S., Wu, C. Y., Chan-Hui, P. Y., Liu, Y., Feizi, T., Zwick, M. B., Koff, W. C., Seaman, M. S., Swiderek, K., Moore, J. P., Evans, D., Paulson, J. C., Wong, C. H., Ward, A. B., Wilson, I. A., Sanders, R. W., Poignard, P., and Burton, D. R. (2014) Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers Immunity 40, 657-668 10.1016/j.immuni.2014.04.009
47. Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., Petropoulos, C. J., and Burton, D. R. (2004) Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies J. Virol. 78, 13232-13252 10.1128/JVI.78.23.13232-13252.2004
48. Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J. P., Wang, S. K., Ramos, A., Chan-Hui, P. Y., Moyle, M., Mitcham, J. L., Hammond, P. W., Olsen, O. A., Phung, P., Fling, S., Wong, C. H., Phogat, S., Wrin, T., Simek, M. D., Koff, W. C., Wilson, I. A., Burton, D. R., and Poignard, P. (2011) Broad neutralization coverage of HIV by multiple highly potent antibodies Nature 477, 466-470 10.1038/nature10373
49. Schnaar, R. L. (2004) Glycolipid-mediated cell-cell recognition in inflammation and nerve regeneration Arch. Biochem. Biophys. 426, 163-172 10.1016/j.abb.2004.02.019
50. Lopez, P. H. and Schnaar, R. L. (2009) Gangliosides in cell recognition and membrane protein regulation Curr. Opin. Struct. Biol. 19, 549-557 10.1016/j.sbi.2009.06.001
51. Dube, D. H. and Bertozzi, C. R. (2005) Glycans in cancer and inflammation - potential for therapeutics and diagnostics Nat. Rev. Drug Discovery 4, 477-488 10.1038/nrd1751
52. Hakomori, S. and Zhang, Y. M. (1997) Glycosphingolipid antigens and cancer therapy Chem. Biol. 4, 97-104 10.1016/S1074-5521(97)90253-2
53. Yuriev, E., Farrugia, W., Scott, A. M., and Ramsland, P. A. (2005) Three-dimensional structures of carbohydrate determinants of Lewis system antigens: implications for effective antibody targeting of cancer Immunol. Cell Biol. 83, 709-717 10.1111/j.1440-1711.2005.01374.x
54. Zhang, S. L., Zhang, H. S., CordonCardo, C., Reuter, V. E., Singhal, A. K., Lloyd, K. O., and Livingston, P. O. (1997) Selection of tumor antigens as targets for immune attack using immunohistochemistry. 2. Blood group-related antigens Int. J. Cancer 73, 50-56 10.1002/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.3.CO;2-O
55. Sakamoto, J., Furukawa, K., Cordoncardo, C., Yin, B. W. T., Rettig, W. J., Oettgen, H. F., Old, L. J., and Lloyd, K. O. (1986) Expression of Lewisa, LewisB, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell-lines Cancer Res. 46, 1553-1561
56. Gandhi, N. S. and Mancera, R. L. (2008) The structure of glycosaminoglycans and their interactions with proteins Chem. Biol. Drug Des. 72, 455-482 10.1111/j.1747-0285.2008.00741.x
57. Capila, I. and Linhardt, R. J. (2002) Heparin-protein interactions Angew. Chem., Int. Ed. 41, 391-412 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B
58. Esko, J. D. and Selleck, S. B. (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate Annu. Rev. Biochem. 71, 435-471 10.1146/annurev.biochem.71.110601.135458
59. Knudson, C. B. and Knudson, W. (2001) Cartilage proteoglycans Semin. Cell Dev. Biol. 12, 69-78 10.1006/scdb.2000.0243
60. Nandini, C. D. and Sugahara, K. (2006) Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors Adv. Pharmacol. 53, 253-279 10.1016/S1054-3589(05)53012-6
61. Deepa, S. S., Umehara, Y., Higashiyama, S., Itoh, N., and Sugahara, K. (2002) Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors-Implications as a physiological binding partner in the brain and other tissues J. Biol. Chem. 277, 43707-43716 10.1074/jbc.M207105200
62. Rogers, C. J., Clark, P. M., Tully, S. E., Abrol, R., Garcia, K. C., Goddard, W. A., and Hsieh-Wilson, L. C. (2011) Elucidating glycosaminoglycan-protein-protein interactions using carbohydrate microarray and computational approaches Proc. Natl. Acad. Sci. U. S. A. 108, 9747-9752 10.1073/pnas.1102962108
63. Sterner, E., Meli, L., Kwon, S. J., Dordick, J. S., and Linhardt, R. J. (2013) FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms Biochemistry 52, 9009-9019 10.1021/bi401284r
64. Knudson, C. B. and Knudson, W. (1993) Hyaluronan-binding proteins in development, tissue homeostasis, and disease FASEB J. 7, 1233-1241
65. Toole, B. P. (1990) Hyaluronan and its binding proteins, the hyaladherins Curr. Opin. Cell Biol. 2, 839-844 10.1016/0955-0674(90)90081-O
66. Xu, Y., Masuko, S., Takieddin, M., Xu, H., Liu, R., Jing, J., Mousa, S. A., Linhardt, R. J., and Liu, J. (2011) Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins Science 334, 498-501 10.1126/science.1207478
67. Cai, C., Dickinson, D. M., Li, L., Masuko, S., Suflita, M., Schultz, V., Nelson, S. D., Bhaskar, U., Liu, J., and Linhardt, R. J. (2014) Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides Org. Lett. 16, 2240-2243 10.1021/ol500738g
68. DeAngelis, P. L., Liu, J., and Linhardt, R. J. (2013) Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature's longest or most complex carbohydrate chains Glycobiology 23, 764-777 10.1093/glycob/cwt016
69. Zong, C., Venot, A., Dhamale, O., and Boons, G. J. (2013) Fluorous supported modular synthesis of heparan sulfate oligosaccharides Org. Lett. 15, 342-345 10.1021/ol303270v
70. Liu, R., Xu, Y., Chen, M., Weiwer, M., Zhou, X., Bridges, A. S., DeAngelis, P. L., Zhang, Q., Linhardt, R. J., and Liu, J. (2010) Chemoenzymatic design of heparan sulfate oligosaccharides J. Biol. Chem. 285, 34240-34249 10.1074/jbc.M110.159152
71. Mammen, M., Choi, S. K., and Whitesides, G. M. (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. 37, 2755-2794 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
72. Lundquist, J. J. and Toone, E. J. (2002) The cluster glycoside effect Chem. Rev. 102, 555-578 10.1021/cr000418f
73. Gordon, E. J., Sanders, W. J., and Kiessling, L. L. (1998) Synthetic ligands point to cell surface strategies Nature 392, 30-31 10.1038/32073
74. Liang, R., Loebach, J., Horan, N., Ge, M., Thompson, C., Yan, L., and Kahne, D. (1997) Polyvalent binding to carbohydrates immobilized on an insoluble resin Proc. Natl. Acad. Sci. U. S. A. 94, 10554-10559 10.1073/pnas.94.20.10554
75. Zhang, Y. L., Campbell, C., Li, Q. A., and Gildersleeve, J. C. (2010) Multidimensional glycan arrays for enhanced antibody profiling Mol. BioSyst. 6, 1583-1591 10.1039/c002259d
76. Wang, L. L., Cummings, R. D., Smith, D. F., Huflejt, M., Campbell, C. T., Gildersleeve, J. C., Gerlach, J. Q., Kilcoyne, M., Joshi, L., Serna, S., Reichardt, N. C., Parera Pera, N. P., Pieters, R. J., Eng, W., and Mahal, L. K. (2014) Cross-platform comparison of glycan microarray formats Glycobiology 24, 507-517 10.1093/glycob/cwu019
77. Manimala, J. C., Roach, T. A., Li, Z., and Gildersleeve, J. C. (2007) High-throughput carbohydrate microarray profiling of 27 antibodies demonstrates widespread specificity problems Glycobiology 17, 17C-23C 10.1093/glycob/cwm047
78. Gildersleeve, J. C. and Wright, W. S. (2016) Diverse molecular recognition properties of blood group A binding monoclonal antibodies Glycobiology 26, 443 10.1093/glycob/cwv171